DONALD A DENKHAUS
CIK 1278439 · last filed 2025-12-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$15.64M
Companies
2
Total Filings
47
Lifetime Open-Market Net
-$13.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CPRX | Director | 498,773 | $31.36 | $15.64M | -$122.9K | 41 | 2025-12-30 |
| NOVEN PHARMACEUTICALS INC (NOVN) Delisted | Director | 0 | $0.09 | $0 | $109.0K | 6 | 2009-08-27 |
Recent Filings · Page 3 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-01-11 | CPRX | Exer (M) | +40,000 | $101.2K | EDGAR |
| 2022-01-06 | CPRX | Exer (M) | +50,000 | $167.5K | EDGAR |
| 2021-12-30 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2021-12-06 | CPRX | Exer (M) | +1,333 | $0 | EDGAR |
| 2021-01-04 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2020-12-23 | CPRX | Exer (M) | +1,333 | $0 | EDGAR |
| 2019-12-04 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2018-12-28 | CPRX | Buy (P) | +25,000 | $47.8K | EDGAR |
| 2018-12-21 | CPRX | Grant (A) | — | $0 | EDGAR |
| 2018-12-17 | CPRX | Buy (P) | +60,000 | $148.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.